Betaliq Launches in Tampa to Focus on Glaucoma

Novaliq GmbH, the Germany pharmaceutical company that markets drugs for eyes diseases using its EyeSol drug delivery technology, and BLP Management, founded and launched Betaliq. Betaliq is headquartered in Tampa, Fla. and will focus on developing drugs for glaucoma. The company launched with $6 million in equity funding, which is still open.